Articles published by ImmunoPrecise Antibodies Ltd.
![](https://mms.businesswire.com/media/20240826542905/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240823192589/en/1747961/5/IPA_Logo_01-03-2023.jpg)
ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements
August 23, 2024
Via Business Wire
Tickers
IPA
![](https://mms.businesswire.com/media/20240729947950/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240723337852/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240716399087/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240715388760/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240627304070/en/1747961/5/IPA_Logo_01-03-2023.jpg)
Via Business Wire
Tickers
IPA
![](https://mms.businesswire.com/media/20240625615288/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240612313286/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240610639834/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240604502257/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240328426956/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240320099936/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240314074244/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240307470977/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20240304754427/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20231214533143/en/1747961/5/IPA_Logo_01-03-2023.jpg)
IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*
December 14, 2023
Via Business Wire
Tickers
IPA
![](https://mms.businesswire.com/media/20231208944275/en/1747961/5/IPA_Logo_01-03-2023.jpg)
IPA Announces Closing of $1.265 Million Public Offering of Common Shares
December 08, 2023
Via Business Wire
Tickers
IPA
![](https://mms.businesswire.com/media/20231206054223/en/1747961/5/IPA_Logo_01-03-2023.jpg)
IPA Announces Pricing of $1.1 Million Public Offering of Common Shares
December 06, 2023
Via Business Wire
Tickers
IPA
![](https://mms.businesswire.com/media/20231205313002/en/1747961/5/IPA_Logo_01-03-2023.jpg)
IPA Announces Proposed Public Offering of Common Shares
December 05, 2023
Via Business Wire
Tickers
IPA
![](https://mms.businesswire.com/media/20231127562186/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20231113700781/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20231025963840/en/1747961/5/IPA_Logo_01-03-2023.jpg)
IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
October 25, 2023
Via Business Wire
Tickers
IPA
![](https://mms.businesswire.com/media/20231023188455/en/1747961/5/IPA_Logo_01-03-2023.jpg)
Via Business Wire
Tickers
IPA
![](https://mms.businesswire.com/media/20230919924394/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20230914565253/en/1747961/5/IPA_Logo_01-03-2023.jpg)
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024
September 14, 2023
Via Business Wire
Tickers
IPA
![](https://mms.businesswire.com/media/20230908399890/en/1747961/5/IPA_Logo_01-03-2023.jpg)
![](https://mms.businesswire.com/media/20230905414481/en/1421460/5/IPA_Tagline_Gray_lg-RGB.jpg)
![](https://mms.businesswire.com/media/20230809246192/en/1747961/5/IPA_Logo_01-03-2023.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.